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Dyskeratosis congenita (DKC) is a rare and fatal congenital syndrome characterized by the triad of reticular skin
pigmentation, nail dystrophy and mucosal leukoplakia, and the predisposition to bone marrow failure and ma-
lignancies. Mutations in DKC1 gene encoding dyskerin are responsible for the X-linked dyskeratosis congenita.
Here we report mutation analysis of two Chinese pedigrees with dyskeratosis congenita. The 15 coding exons of
DKC1 and their ﬂanking regions were ampliﬁed from genomic DNA by PCR. DNA sequencing and restriction
endonuclease digestion were used for mutation detection. Transition mutation of 1226C ! T (P409L) found in the
ﬁrst pedigree is a novel mutation. In the second pedigree, the proband’s mother phenotypically normal carried a
de novo transition mutation of 1058C ! T (A353V) in one allele, and transmitted the mutant allele to her two sons
who had typical manifestations of dyskeratosis congenita.
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Dyskeratosis congenita (DKC) is a rare heritable disorder
characterized by the triad of reticular skin pigmentation, nail
dystrophy, and mucosal leukoplakia. Progressive bone mar-
row failure develops in more than 40% of the patients by the
age of 10 y and in more than 80% of the patients by the age
of 30 y, which is the main cause of early mortality (Knight
et al, 1998). Several types of malignancies are also frequently
complicated (Knight et al, 1998). The clinical features of
DKC suggest that tissues in active renewal may be most
vulnerable to this genetic abnormality.
DKC is a genetically heterogeneous disease (Dokal,
2000). The X-linked form accounts for most of the disease
with more than 90% of the patients being males. Autosomal
recessive and autosomal dominant DKC are only occasion-
ally encountered. Mutations in DKC1 gene which encodes
dyskerin were identified to be responsible for the X-linked
DKC by positional cloning (Heiss et al, 1998). Since then a
variety of DKC1 mutations have been characterized (Knight
et al, 1999), however, previous reports of mutations did not
accompany detailed description of their clinical features.
Here we report two Chinese pedigrees with the X-linked
form of DKC. Five patients with typical mucocutaneous
triad were found in the two families. A novel mutation
of 1226C ! T (P409L) and a de novo mutation of
1058C ! T (A353 V) in DKC1 were identified. This is the
first report of DKC mutation analysis in Chinese patients.
Results
For the three affected members (III:5, 9, and 13) of the first
pedigree (Fig 1a), sequencing of the PCR products ampli-
fied from exon 12 of the DKC1 revealed a transition muta-
tion of C to T in the coding region at nucleotide position
1226 (numbered from the A of the translation initiation co-
don ATG) (Fig 2a). Sequencing of the repeated PCR prod-
ucts from the opposite direction confirmed the mutation
(Fig 2b). This missense mutation caused a replacement of the
normal proline at amino acid residue 406 by leucine (P409L)
in dyskerin. No mutation was found in the other exons or
their flanking regions. Sequencing of the PCR products
amplified from the patients’ mothers (II:5, 7, and 9), mater-
nal grandmothers (I:2), and one sister (III:12) showed het-
erozygous 1226C ! T mutation (Fig 2c). No such mutation
was found in rest of the family members or in the 50 un-
related controls (Fig 2d). The BspMI digestion of the 227bp
PCR product amplified from exon 12 yielded two fragments
of 150 and 77 bp from the wild-type allele, and a 227 bp
fragment from the mutant allele. As shown in Fig 1c, the
BspMI digestion confirmed that the three male patients
(III:5, 9, and 13) had one same mutant allele. Their mothers
(II:5, 7, and 9), maternal grandmother (I:2), and one sister
(III:12) carried one mutant allele and one wild-type allele.
Their fathers (II:6 and 8) and the proband’s sibling sister
(III:14) had normal alleles.
In the second pedigree (Fig 1b), the proband (IV:2) and
his brother (IV:3) were identified to have a transition muta-
tion of 1058C ! T (Figs 2e and 1d) which resulted in
an amino acid change of A353 V in dyskerin. Their mother
(III:7) and sister (IV:1) carried a heterozygous 1058C ! T1These two authors contributed equally to the article.
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mutation (Figs 2f and 1d), but their maternal grandparents
(II:3 and 4) did not have this mutant allele (Fig 1d). Micro-
satellite markers proved that their mother (III:7) was the bi-
ological daughter of their grandparents (II:2 and 3), and the
1058C ! T mutation was therefore a de novo event begin-
ning from proband’s mother (III:7).
Discussion
Symptoms of DKC usually begin during patients’ childhood.
Mucocutaneous features including pigmentation of skin,
nail dystrophy, and leukoplakia appear between the ages of
5–10 y (Knight et al, 1998). Apart from the typical triad
manifestations, a variety of other clinical findings have also
been described (Dokal, 2000). Dysphagia, epiphora, and
dysuria are common symptoms resulting from constriction
of the mucosal surface of esophagus, lacrimal ducts, and
urethra. Our five patients were diagnosed as DKC based on
the clinical manifestations of reticulate pigmentation, nail
dystrophy, and oral leukoplakia, although no other systemic
involvements were found at the present time. DKC patients
are usually complicated with hemotopoietic deficiency in
the second or third decade of life, and malignancies in-
cluding squamous cell carcinomas of skin or mucosa in the
third or fourth decade (Dokal, 2000). Therefore, the patients
should be closely followed.
DKC presents as an X-linked recessive, autosomal re-
cessive or autosomal dominant inherited disease. Most of
the DKC families are of X-linked recessive inheritance, with
Figure 1
The two DKC pedigrees and muta-
tion identification by endonuclease
restriction enzyme digestion. Ar-
row, proband; star, DNA sample avail-
able; M, pBR322 DNA/MspI marker;
N, normal control. (a) The first pedi-
gree. (b) the second pedigree, (c)
PCR products amplified from exon
12 of DKC1 were digested with
BspMI and separated in polyacryl-
amide gel, and (d) PCR products from
exon 11 of DKC1 were digested with
MspA1 I and separated in polyacryl-
amide gel.
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90% of the DKC patients being males (Dokal, 2000). Mu-
tations in the DKC1 gene are responsible for the X-linked
DKC (Heiss et al, 1998). Autosomal dominant form of DKC is
caused by mutations in the hTR gene (Vulliamy et al, 2001).
In this study, all of the patients were males, whose parents
and sisters presented with normal phenotype, suggesting
the X-linked recessive inheritance in the two families. We
therefore chose DKC1 for mutation search.
The DKC1 gene consists of 15 exons and spans a 15 kb
region at Xq28. DKC1 encodes the nucleolar protein
dyskerin and is ubiquitously expressed in tissues (Heiss et al,
1998; Hassock et al, 1999). Most mutations responsible for
DKC are missense mutations in the coding regions of the
gene (Heiss et al, 1998; Hassock et al, 1999; Knight et al,
1999). In addition, two putative splicing mutations in introns
1 and 2 (Knight et al, 1999; Knight et al, 2001), a single
amino acid deletion (Heiss et al, 1998), a 2 kb deletion of
exon 15 (Heiss et al, 1998), and a mutation in the upstream
regulatory region within a putative Sp1 binding site (Knight
et al, 2001) have also been described. No correlation,
however, was found between the type of mutation in DKC1
and the phenotype of the disease. The substitution of
1226C ! T (P409L) found in patients in the first pedigree
was not reported previously. In the first pedigree, the three
patients’ mothers and their maternal grandmother carried a
heterozygous 1226C ! T mutation, however they were un-
affected, indicating the typical X-linked recessive inherit-
ance. The de novo 1058C ! T mutation as seen in our
second pedigree has been reported several times. There-
fore, the 1058C ! T mutation may be a hotspot for de novo
mutation in DKC (Knight et al, 1999, 2001).
The pathological consequences of mutations in dyskerin
remain unknown. Dyskerin is a putative pseudouridine synt-
hase that localizes in a complex with box H/ACA small
nucleolar RNAs and mediates posttranscriptional modifica-
tion of ribosomal RNA through the conversion of uridine to
pseudouridine (Heiss et al, 1998; Knight et al, 1999).
Dyskerin is also associated with the RNA component of
human telomerase that contains an H/ACA RNA motif
(Mitchell et al, 1999a) and DKC was proposed to be caused
by the defects in the maintenance of telomeres (Blasco
et al, 1997; Mitchell et al, 1999b). Recent results from Dkc1
mutant mice suggest that ribosome malfunction is impor-
tant in the initiation of DKC, whereas telomere shortening
may modify and/or exacerbate DKC (Ruggero et al, 2003).
Further studies of DKC patients are necessary to under-
stand the role of mutant dyskerin in the pathogenesis of
DKC and its hematological and malignant complications.
Materials and Methods
Patients In the first pedigree (Fig 1a), three patients were found
among 26 members who came from the Hebei province in North-
ern China. The proband (III:13) was a 20-y-old Chinese male with
skin lesions, nail dystrophy, and oral mucosa erosions since child-
hood. He developed epiphora, dysphagia, and dysuria during ad-
olescence and the symptoms deteriorated with age. The mental
and physical development was normal. Physical examination re-
vealed generalized reticulation of hyperpigmentation, hypopig-
mentation, and fine telangiectatic erythema, prominently on face,
trunk and limbs (Fig 3a). All of his nails were found dystrophic (Fig
3b and c), and the finger tips became shiny and smooth. Erosions
and dystrophy with patches of leukoplakia were found on his
buccal mucosa, tongue (Fig 3d), and coronary sulcus of the penis
(Fig 3e), however, the teeth were normal. Eye involvement included
recurrent conjunctivitis and excessive lacrimation. Routine labora-
tory examinations including blood counts, urinalysis, serum elec-
trolytes, hepatic and renal function tests, and immunoglobulin
Figure 2
Direct sequencing of PCR products amplified from DKC1 gene (GenBank accession number NT-025965). Arrows indicate the positions of
mutated bases. (a–d) Sequencing of PCR products from exon 12. (a) 1226C ! T mutation from the proband (III:13) of the first pedigree. (b)
Sequencing from the opposite direction confirms the 1226C ! T mutation from the proband. (c) Heterozygous 1226C ! T mutation from family
member II:9 of the first pedigree. (d) Sequencing of a normal control. (e–g): Sequencing of PCR products from exon 11. (e) 1058C ! T mutation from
the proband (IV:2) of the second pedigree. (f) Heterozygous 1058C ! T mutation from family member III:7 of the second pedigree. (g) Sequencing of
a normal control.
472 DING ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
levels as well as chest X-ray and ECG were within normal limits. A
punch biopsy taken from hyperpigmented lesions on the dorsal
skin revealed atrophic epidermis with areas of hyperpigmentation
in the basal layer; and melanophages, telangiectasia and mild in-
filtration of inflammatory cells in the superficial dermis. Blister
forming was observed beneath the epidermis due to liquefaction
degeneration of the basal cells (Fig 3f). The other two patients (III:5
and 9) were both 20 y old and had similar manifestations.
In the second pedigree (Fig 1b), two members were affected
among 20 people. The proband (IV:2) was a 19-y-old male. He was
normal until the age of 5 y when he developed erosion on oral
mucosa followed by nail dystrophy. At the age of 10 y, he had skin
dyspigmentation, palmoplantar hyperkeratosis, dysphagia, and
epiphora. No other abnormalities were found. His younger brother
(IV:3, 16 y old) had similar but less severe manifestations. Other
living members in the two families were examined and no stigmata
of DKC were found.
Mutation detection The studies performed were approved by the
Institutional Review Board of the Peking University First Hospital.
With informed consent, we collected blood samples of attainable
individuals in the two pedigrees as well as 50 unrelated normal
individuals for controls. Genomic DNA was isolated from peripheral
white blood cells. The coding exons of the DKC1 gene and the
flanking regions (GenBank accession number NT025965) were
amplified by polymerase chain reaction (PCR). The primers for the
amplification of exon 11 were: forward primer 50-tccatatgcacatcct-
gagc and reverse primer 50-tccccctctgtgagaaacac. The primers
for the amplification of exon 12 were: forward primer 50-attctttgtag-
tcaccatgcc and reverse primer 50-agcaa gtgtgccgtctctacc. PCR
products were purified by electrophoresis in agarose gel and se-
quenced using an automated sequencer (ABI Model 377, Applied
Biosystems, Foster City, California). The mutations of 1226C ! T
in exon 12 and 1058 C ! T in exon 11 eliminate the normal BspMI
site and MspA1 I site, respectively. Mutations were further con-
firmed by digestion of PCR products with the two endonuclease
restriction enzymes at 371C for 4 h, electrophoresis in 8% polya-
crylamide gel and staining with silver nitrate.
Paternity identiﬁcation To confirm the de novo mutation of
1058C ! T in the second pedigree (Fig 1b), the DNA samples
from the proband’s mother (III:7) and maternal grandparents (II:3
and 4) were sent to the Criminal Investigation Center of Beijing
Public Security Bureau for paternity identification using the 16
highly polymorphic microsatellite markers and Identifiler Kit (Ap-
plied Biosystems, Foster City, California).
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Figure 3
Clinical data of the DKC proband in the first pedigree. (a) Hyper-
pigmentation, hypopigmentation, and fine telangiectatic erythema on
the neck. (b, c) Dystrophy of nails. (d, e) Dystrophy with patches of
leukoplakia on tongue and coronary sulcus of the penis. (f) Skin biopsy
from a hyperpigmentation site shows atrophic epidermis with areas of
hyperpigmentation in the basal layer, and melanophages, telangiect-
asia, and mild infiltration of inflammatory cells in the superficial dermis.
Blister beneath the epidermis due to liquefaction degeneration of the
basal cells. Scale bar¼ 100mm.
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